PN-943 in Adults With Moderate to Severe Active Ulcerative Colitis (UC)
NCT04504383
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
169
Enrollment
INDUSTRY
Sponsor class
Conditions
Ulcerative Colitis Chronic Moderate
Ulcerative Colitis Chronic Severe
Interventions
DRUG:
PN-943
DRUG:
Placebo
Sponsor
Protagonist Therapeutics, Inc.